Zhou, Ning
Zhao, Yuhua
Jiang, Jiangang
Shen, Lan
Li, Junming
Wan, Jing
Ma, Xueping
Zhang, Jing
Ammirati, Enrico
Wang, Dao Wen
Funding for this research was provided by:
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (82070316, 81790624, 81630010, 2017YFC0909400)
Article History
Received: 25 November 2020
Revised: 22 May 2021
Accepted: 7 June 2021
First Online: 6 October 2021
Competing interests
: No author had potential conflicts of interest involving the work under consideration for publication. E.A. received honoraria for participation to advisory board from Kiniksa Pharmaceutical in the last 3 years. Dao Wen Wang is the editorial board member of <i>Signal Transduction and Targeted Therapy</i>, but he has not been involved in the process of the manuscript handling.